CytomX Therapeutics announced the promotion of Chris Ogden to CFO effective June 15. Ogden joined CytomX in August of 2021 as VP, finance and accounting and has since served in roles of increasing responsibility spanning finance, accounting, investor relations, capital raising, information technology, and facilities, most recently as senior VP, finance and accounting.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTMX:
- Largest borrow rate increases among liquid names
- CytomX upgraded on pancreatic cancer data at Piper Sandler
- CytomX Therapeutics upgraded to Overweight from Neutral at Piper Sandler
- CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
- CytomX Therapeutics Announces New Employment Inducement Grants